Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- IC-MedTech Corporation
- Target Recruit Count
- 13
- Registration Number
- NCT05523596
- Locations
- 🇺🇸
Parkway Medical, Glen Burnie, Maryland, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
🇺🇸Culmore Clinic, Falls Church, Virginia, United States
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
Phase 2
Completed
- Conditions
- OsteolysisForeign Body ReactionEdematousSynovitis
- Interventions
- Drug: Apatone®BDrug: Placebo
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- IC-MedTech Corporation
- Target Recruit Count
- 57
- Registration Number
- NCT01272830
- Locations
- 🇺🇸
Summa Health System, Akron, Ohio, United States
News
No news found